BOLT Lithotripsy RESTORE ATK Trial

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

July 30, 2024

Conditions
Peripheral Arterial DiseasePeripheral Vascular Diseases
Interventions
DEVICE

Intravascular Lithotripsy

Enhancing percutaneous transluminal angioplasty by utilizing delivery of IVL to disrupt calcium in above the knee lesions prior to full balloon dilatation at low pressures

Trial Locations (11)

1090

Universitätsklinik für Innere Medizin II, Vienna

48149

Universitätsklinikum Münster (UKM), Münster

60389

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt

Unknown

Medical University of Graz, Graz

Mein Hanusch Krankenhaus, Vienna

University Hospital of Split, Split

Klinikum Hochsauerland GmbH, Arnsberg

Universitätsklinikum Freiburg Universitäts-Herzzentrum, Bad Krozingen

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt

GRN Klinik Weinheim, Weinheim

D-48145

St. Franziskus-Hospital GmbH, Münster

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bolt Medical

INDUSTRY

NCT05662787 - BOLT Lithotripsy RESTORE ATK Trial | Biotech Hunter | Biotech Hunter